ArticleScientific data2025
MultiD4CAD: Multimodal Dataset composed of CT and Clinical Features for Coronary Artery Disease Analysis.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MultiD4CAD: Multimodal Dataset composed of CT and Clinical Features for Coronary Artery Disease Analysis.Scientific data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multimodal datasets offer valuable support for developing Clinical Decision Support Systems (CDSS), which leverage predictive models to enhance clinicians' decision-making. In this observational study, we present a dataset of suspected Coronary Artery Disease (CAD) patients - called MultiD4CAD - comprising imaging and clinical data. The imaging data obtained from Coronary Computed Tomography Angiography (CCTA) includes epicardial (EAT) and pericoronary (PAT) adipose tissue segmentations. These metabolically active fat tissues play a key role in cardiovascular diseases. In addition, clinical data include a set of biomarkers recognized as CAD risk factors. The validated EAT and PAT segmentations make the dataset suitable for training predictive models based on radiomics and deep learning architectures. The inclusion of CAD disease labels allows for its application in supervised learning algorithms to predict CAD outcomes. MultiD4CAD has revealed important correlations between imaging features, clinical biomarkers, and CAD status. The article concludes by discussing some challenges, such as classification, segmentation, radiomics, and deep training tasks, that can be investigated and validated using the proposed dataset.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.